[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366024-105":59,"doc-detail-366024-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","chemoprevention-of-keratinocyte-cancers-could-aspirin-be-the-solution","Chemoprevention of Keratinocyte Cancers - Could Aspirin Be the Solution","","Chemoprevention of keratinocyte cancers addresses a rapidly growing skin cancer burden in Australia, especially among older adults with high ultraviolet exposure. Keratinocyte cancers account for substantial hospitalisations and treatment costs, with immunosuppressed patients facing markedly higher risk and greater clinical complexity. The review discusses aspirin as a longstanding chemopreventive candidate evaluated in other cancers. It outlines the urgency for efficacious, tolerable and safe prevention strategies and focuses on how aspirin may reduce keratinocyte cancer incidence.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/chemoprevention-of-keratinocyte-cancers-could-aspirin-be-the-solution/366024/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/chemoprevention-of-keratinocyte-cancers-could-aspirin-be-the-solution/366024.png","ImageObject",300,407,{"name":92,"@type":93},"Aditya","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-30","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is chemoprevention for keratinocyte cancers urgently needed?","Question",{"text":112,"@type":113},"Keratinocyte cancer incidence is rising and creates large strains on healthcare, with substantial hospitalisation rates and annual treatment costs. The review highlights an acute need for safe, tolerable agents that can reduce this burden.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"Who is at highest risk of keratinocyte cancers?",{"text":117,"@type":113},"Immunosuppressed individuals, including those with haematological malignancy and solid organ transplant recipients, are described as being at highest risk. Older adults and UV-exposed Caucasian populations are also increasingly requiring treatment.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does aspirin play in this narrative review?",{"text":121,"@type":113},"The review discusses aspirin as a potential chemopreventive agent for keratinocyte cancers, building on its investigation in other cancer types. It frames aspirin as a candidate strategy for decreasing keratinocyte cancer incidence.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366024,1790813037,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":36,"preview_page_count":19,"preview_urls":145},962085564549,"https://ap-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","Review  \n[http://www.jcpjournal.org](http://www.jcpjournal.org)  \npISSN 2288-3649 · eISSN 2288-3657 [https://doi.org/10.15430/JCP.25.007](https://doi.org/10.15430/JCP.25.007)  \nChemoprevention of Keratinocyte Cancers: Could Aspirin Be the Solution?  \nEmma Hiscutt1,2, Suzanne Orchard1, Rory Wolfe1, Victoria Mar1,2  \n1School of Public Health and Preventive Medicine, Monash University, 2Victorian Melanoma Service, Alfred Health, Melbourne, Australia  \nKeratinocyte cancer burden is escalating, particularly in older Australian adults, where the incidence was > 6,000/100,000 in persons aged 80 to 84 per year, compared with 26/100,000 in persons aged 20 to 24 per year, in Queensland between 2011 to 2014. Keratinocyte cancers are estimated to account for 25% of all cancer-related hospitalisations and > $1 billion in treatment costs per year in Australlia. This undoubtedly leads to a large strain on the medical system, as well as amplifying patient morbidity and mortality. Those who are immunosuppressed, or with haematological malignancy or a solid organ transplant, are typically at highest risk of developing a keratinocyte cancer; however, older adults, and especially UV exposed Caucasian populations are increasingly requiring treatment for several keratinocyte cancers every year. This has resulted in an acute, urgent need for efficacious, tolerable, safe chemoprevention agents that could decrease keratinocyte cancer burden. Aspirin has been investigated as a chemopreventive agent for many years in other cancers. In this narrative review, the role for aspirin in the chemoprevention of keratinocyte cancers is discussed.  \nKey Words Aspirin, Squamous cell carcinoma, Basal cell carcinoma, Keratinocyte carcinoma, Chemoprevention  \nINTRODUCTION  \nThe incidence of skin cancer is rising alarmingly in Australia, with two in three Australians to be diagnosed with skin cancer before the age of 70 [1], which is estimated to account for 25% of all cancer-related hospitalisations and > $1 billion in treatment costs per year [2] . This is primarily due to the extremely high incidence of keratinocyte cancers (KC), which include squamous cell carcinoma (SCC) and basal cell carcinoma (BCC), derived from epidermal keratinocytes. The highest worldwide incidence of SCC is 425 per 100,000 person per year in New Zealand [3,4] and Australian incidence encroached this, at 341 per 100,000 men/year and 209 per 100,000 women/year, between 2011 to 2014. The Australian BCC incidence was more than double at 899 per 100,000 men/year and 656 per 100,000 women/year [5] . In addition to male sex, KC incidence soared in older individuals, with > 6,000 per 100,000 in persons aged 80 to 84 per year, compared with 26 per 100,000 in persons aged 20 to 24 per year [5] . The KC incidence is highest in Queensland, where the average UV index is higher than that in other states [5] .  \nDeveloping multiple primary KC is substantially more likely after one KC; an Australian study showed that the person-based rate of KC excisions was 8 times higher in those with a history of KC, after adjustment for age and sex (standardised incidence ratios = 8.4; 95% CI: 8.3, 8.6) [5] . KC multiplicity is particularly challenging for immunosuppressed patients. Solid organ transplant recipients have a 65 to 250 times increased risk of developing SCC, compared with the general population [6-8], and KC are the most common cause of cancer deaths (14 .5%) [9] . A tertiary referral centre in Melbourne Australia reported a high accrual rate for SCCof 0.89 SCC/patient/year in renal transplant patients who received immunosuppressive medication [10]; immunosuppression impairs the immune system’s capacity to repair or destroy UV damaged keratinocytes, allowing them to transform into skin cancers. Immunosuppression is both disease-and treatment-related in chronic lymphocytic leukaemia (CLL) and non-Hodgkin’s lymphoma, and an American study reported that 29.9% of patients developed KC [11], compared to 7.6% ","cbCaidfjCvdls9t6","https://ap.wps.com/l/cbCaidfjCvdls9t6","pdf",877372,16,"English","# Introduction\n## Rising keratinocyte cancer incidence in Australia\n## Risk amplification in immunosuppressed populations\n## Economic burden and need for chemoprevention","[{\"question\":\"Why is chemoprevention for keratinocyte cancers urgently needed?\",\"answer\":\"Keratinocyte cancer incidence is rising and creates large strains on healthcare, with substantial hospitalisation rates and annual treatment costs. The review highlights an acute need for safe, tolerable agents that can reduce this burden.\"},{\"question\":\"Who is at highest risk of keratinocyte cancers?\",\"answer\":\"Immunosuppressed individuals, including those with haematological malignancy and solid organ transplant recipients, are described as being at highest risk. Older adults and UV-exposed Caucasian populations are also increasingly requiring treatment.\"},{\"question\":\"What role does aspirin play in this narrative review?\",\"answer\":\"The review discusses aspirin as a potential chemopreventive agent for keratinocyte cancers, building on its investigation in other cancer types. It frames aspirin as a candidate strategy for decreasing keratinocyte cancer incidence.\"}]","Chemoprevention of Keratinocyte Cancers - Could Aspirin Be the Solution | PDF",1790163589,[146,150,154,158],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9612da9aee726f1ab44f1275af6df25e.webp",983,1310,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/74745322af0c23903cc17a8920b21fce.webp",982,1309,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5c1e3cee3cb0692a504f5d2cd4babfa4.webp",981,1308,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ca08506ac97d6a3f0e634174f4741908.webp",980,1306]